Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT04511416
PHASE3
Preventing Cognitive Decline with Metformin
Sponsor: Garvan Institute of Medical Research
View on ClinicalTrials.gov
Summary
A randomised control study of metformin in people with mild cognitive impairment and without diabetes mellitus to determine effects on cognitive decline and neuroimaging over 3 years.
Official title: Preventing Cognitive Decline with Metformin:: the MetMemory Study
Key Details
Gender
All
Age Range
60 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
242
Start Date
2022-07-15
Completion Date
2027-12
Last Updated
2024-10-02
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Metformin XR, 500-2000mg nocte
Metformin XR, 500-2000mg nocte
Locations (1)
Garvan Institute of Medical Research
Sydney, New South Wales, Australia